JP Morgan Chase
BNR

JP Morgan Chase’s Burning Rock Biotech BNR Stock Holding History

JP Morgan Chase’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34K Sell
166
-21
-11% -$297 ﹤0.01% 7290
2026
Q1 		$2.99K Buy
+187
New +$4.9K ﹤0.01% 6954
2025
Q4 		– Sell
-64
Closed -$554 – 7442
2025
Q3 		$554 Buy
64
+13
+25% +$93 ﹤0.01% 7043
2025
Q2 		$161 Sell
51
-69
-58% -$214 ﹤0.01% 6798
2025
Q1 		$504 Hold
120
– – ﹤0.01% 6704
2024
Q4 		$810 Hold
120
– – ﹤0.01% 6755
2024
Q3 		$392 Hold
120
– – ﹤0.01% 6824
2024
Q2 		$755 Hold
120
– – ﹤0.01% 6646
2024
Q1 		$876 Buy
+120
New +$1K ﹤0.01% 6657
2023
Q4 		– Sell
-22
Closed -$210 – 7534
2023
Q3 		$210 Hold
22
– – ﹤0.01% 6837
2023
Q2 		$486 Buy
+22
New +$584 ﹤0.01% 6550
2021
Q4 		– Sell
-8,506
Closed -$1.52M – 6647
2021
Q3 		$1.52M Sell
8,506
-12,399
-59% -$2.76M ﹤0.01% 3988
2021
Q2 		$6.16M Buy
20,905
+5,865
+39% +$1.74M ﹤0.01% 2865
2021
Q1 		$4.05M Sell
15,040
-8,099
-35% -$2.47M ﹤0.01% 3155
2020
Q4 		$5.35M Buy
23,139
+9,858
+74% +$2.65M ﹤0.01% 2757
2020
Q3 		$3.22M Sell
13,281
-36,005
-73% -$8.53M ﹤0.01% 2906
2020
Q2 		$13.3M Buy
+49,286
New +$13.5M ﹤0.01% 1681

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CL
CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's BNR Position: Q2 2026 in Review

JP Morgan Chase reduced its Burning Rock Biotech (BNR) stake by 11% in Q2 2026, selling an estimated $297 and leaving 166 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #7290.

JP Morgan Chase first reported a position in BNR in Q2 2020 and has held it in 17 quarters since. The position peaked at $13.3M in Q2 2020. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • JP Morgan Chase held 166 shares of Burning Rock Biotech worth $1.34K as of Q2 2026.
  • JP Morgan Chase sold 21 Burning Rock Biotech shares in Q2 2026, an estimated $297.
  • Burning Rock Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7290 holding.
  • JP Morgan Chase first reported a position in Burning Rock Biotech in Q2 2020 and has held it in 17 quarters since.
  • JP Morgan Chase's Burning Rock Biotech position peaked at $13.3M in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.